MedTrace Logo

Study of the Efficacy of 24 Chromosome Preimplantation Genetic Diagnosis (PGD)

NCT01219283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 334

Last updated 2015-03-26

No results posted yet for this study

Summary

The purpose of this study is to determine if 24 chromosome preimplantation genetic diagnosis (PGD) increases implantation and delivery rates in couples attempting to conceive through in vitro fertilization (IVF).

Conditions

  • Effect of PGD on Implantation Rates in IVF Cycles

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Richard T Scott, MD · Reproductive Medicine Associates of New Jersey

Eligibility

Min Age
21 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01219283 on ClinicalTrials.gov